.gif "LifePoint Health logo")
Regent Investment Management LLC held its stake in LifePoint Health, Inc. (NASDAQ:LPNT) during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,509 shares of the company’s stock at the end of the second quarter. Regent Investment Management LLC’s holdings in LifePoint Health were worth $236,000 at the end of the most recent quarter.
Other hedge funds also recently added to or reduced their stakes in the company. Norges Bank bought a new stake in LifePoint Health during the fourth quarter worth $19,865,000. California Public Employees Retirement System increased its stake in LifePoint Health by 1.2% in the first quarter. California Public Employees Retirement System now owns 179,286 shares of the company’s stock worth $11,743,000 after buying an additional 2,100 shares during the last quarter. Profit Investment Management LLC increased its stake in LifePoint Health by 34.4% in the first quarter. Profit Investment Management LLC now owns 38,060 shares of the company’s stock worth $2,493,000 after buying an additional 9,732 shares during the last quarter. Alliancebernstein L.P. increased its stake in LifePoint Health by 4.2% in the first quarter. Alliancebernstein L.P. now owns 1,725,943 shares of the company’s stock worth $113,049,000 after buying an additional 68,886 shares during the last quarter. Finally, Highbridge Capital Management LLC increased its stake in LifePoint Health by 306.4% in the fourth quarter. Highbridge Capital Management LLC now owns 14,365 shares of the company’s stock worth $816,000 after buying an additional 10,830 shares during the last quarter. Hedge funds and other institutional investors own 99.54% of the company’s stock.
LifePoint Health, Inc. (LPNT) opened at 65.50 on Friday. The stock’s 50 day moving average price is $64.84 and its 200-day moving average price is $62.76. The firm has a market cap of $2.64 billion, a PE ratio of 17.28 and a beta of 0.88. LifePoint Health, Inc. has a 12-month low of $50.60 and a 12-month high of $70.95.
LifePoint Health (NASDAQ:LPNT) last posted its quarterly earnings data on Friday, April 28th. The company reported $1.07 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.01 by $0.06. The company had revenue of $1.63 billion during the quarter, compared to analyst estimates of $1.64 billion. LifePoint Health had a return on equity of 7.06% and a net margin of 2.26%. The firm’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter last year, the company earned $0.85 earnings per share. Equities research analysts anticipate that LifePoint Health, Inc. will post $4.19 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “Regent Investment Management LLC Has $236,000 Position in LifePoint Health, Inc. (NASDAQ:LPNT)” was first reported by StockNewsTimes and is the sole property of of StockNewsTimes. If you are reading this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright law. The original version of this story can be read at https://stocknewstimes.com/2017/07/21/regent-investment-management-llc-has-236000-position-in-lifepoint-health-inc-nasdaqlpnt.html.
LPNT has been the subject of a number of recent analyst reports. Deutsche Bank AG initiated coverage on LifePoint Health in a research report on Tuesday, April 4th. They set a “hold” rating and a $68.00 target price for the company. Mizuho upped their target price on LifePoint Health from $57.00 to $62.00 and gave the company a “neutral” rating in a research report on Monday, March 27th. BidaskClub upgraded LifePoint Health from a “hold” rating to a “buy” rating in a research report on Friday, June 30th. Zacks Investment Research upgraded LifePoint Health from a “hold” rating to a “buy” rating and set a $73.00 target price for the company in a research report on Thursday, July 13th. Finally, Morgan Stanley initiated coverage on LifePoint Health in a research report on Tuesday, June 6th. They set an “equal weight” rating and a $65.00 target price for the company. Two research analysts have rated the stock with a sell rating, ten have issued a hold rating and six have assigned a buy rating to the company. LifePoint Health has an average rating of “Hold” and a consensus price target of $66.08.
In related news, Director Richard H. Evans sold 2,000 shares of LifePoint Health stock in a transaction on Thursday, May 11th. The stock was sold at an average price of $62.88, for a total transaction of $125,760.00. Following the completion of the sale, the director now owns 17,718 shares of the company’s stock, valued at $1,114,107.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Chairman William F. Carpenter III sold 82,347 shares of LifePoint Health stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $64.15, for a total value of $5,282,560.05. Following the sale, the chairman now directly owns 504,535 shares of the company’s stock, valued at approximately $32,365,920.25. The disclosure for this sale can be found here. Insiders have sold 102,000 shares of company stock valued at $6,556,824 in the last three months. 7.28% of the stock is owned by corporate insiders.
LifePoint Health Company Profile
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
